deferiprone and tyrosine

deferiprone has been researched along with tyrosine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buchle, AM; Steulet, AF; Waldmeier, PC1
Ji, L; Li, L; Liu, R; Liu, X; Mu, S; Sui, M; Wang, M; Xie, R; Zou, C1

Other Studies

2 other study(ies) available for deferiprone and tyrosine

ArticleYear
Inhibition of catechol-O-methyltransferase (COMT) as well as tyrosine and tryptophan hydroxylase by the orally active iron chelator, 1,2-dimethyl-3-hydroxypyridin-4-one (L1, CP20), in rat brain in vivo.
    Biochemical pharmacology, 1993, Jun-22, Volume: 45, Issue:12

    Topics: Administration, Oral; Animals; Catechol O-Methyltransferase Inhibitors; Corpus Striatum; Deferiprone; Deferoxamine; Dopamine; Female; Hydroxyindoleacetic Acid; Iron Chelating Agents; Male; Pyridones; Rats; Serotonin; Tryptophan Hydroxylase; Tyrosine; Tyrosine 3-Monooxygenase

1993
Effect of the oral iron chelator deferiprone in diabetic nephropathy rats.
    Journal of diabetes, 2017, Volume: 9, Issue:4

    Topics: Administration, Oral; Animals; Blotting, Western; Chemokine CCL2; Cyclooxygenase 2; Deferiprone; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Carbohydrates; Dose-Response Relationship, Drug; Gene Expression; Immunohistochemistry; Iron Chelating Agents; Kidney; Male; Matrix Metalloproteinase 9; Microscopy, Electron, Transmission; NF-kappa B; Protective Agents; Pyridones; Random Allocation; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Tissue Inhibitor of Metalloproteinase-1; Tyrosine

2017